HOUSTON: Axovant Sciences (NASDAQ:AXON)‘s stock had its “sell” rating reiterated by stock analysts at Chardan Capital in a research report issued to clients and investors.
The company’s stock had a trading volume of 626,746 shares. Axovant Sciences has a 52-week low of $12.75 and a 52-week high of $31.17. The firm’s market capitalisation is $964.50 million. The firm has a 50-day moving average price of $18.68 and a 200 day moving average price of $18.99.